White Biotech New Drug Co., Ltd. Q4 2025 Financials
NQ Score
47/100
N1 Content Completeness
3
AI Summary (NQ-processed)
White Biotech New Drug Co., Ltd. reported a basic earnings per share of -0.29 NTD, operating revenue of 135 million NTD, and a net loss after tax of 110 million NTD for Q4 2025.
AI analysis data is not yet available.